Shafali Spurling Jeste is professor of neurology and pediatrics at the Keck School of Medicine of the University of Southern California. She is also chief of neurology at Children’s Hospital Los Angeles (CHLA).
Shafali Spurling Jeste
Professor of neurology and pediatrics, University of Southern California;
Chief of neurology, Children’s Hospital Los Angeles
From this contributor
Leveraging the power of community to strengthen clinical trials for rare genetic syndromes
Families can become not only participants but champions of these research efforts.
Leveraging the power of community to strengthen clinical trials for rare genetic syndromes
By
Shafali Spurling Jeste
11 July 2024 | 7 min read
Telehealth may enable remote participation in autism trials
Some families do not have the financial ability or time to participate in clinical trials for autism. New technologies may enable them to participate from their homes.
Telehealth may enable remote participation in autism trials
By
Shafali Spurling Jeste
3 March 2020 | 6 min read
Reaching out to families can inspire new autism research
For students and early-career investigators, opportunities to meet and talk with the people they are trying to help underscores why the work matters.
Reaching out to families can inspire new autism research
By
Shafali Spurling Jeste
29 January 2019 | 8 min read
How treating sleep may ease all forms of autism
Behavioral interventions and medications can help children with autism-related syndromes sleep better, but the treatments must be tailored to the cause of each child’s sleep disturbance.
How treating sleep may ease all forms of autism
By
Shafali Spurling Jeste
31 October 2017 | 5 min read
Tennis program serves up benefits for children with autism
Tennis is a social game, requiring players to predict and respond to their opponent’s behavior. That may help some children with autism.
Tennis program serves up benefits for children with autism
By
Shafali Spurling Jeste
7 March 2017 | 9 min read
Explore more from The Transmitter
Psychedelics research in rodents has a behavior problem
Simple behavioral assays—originally validated as drug-screening tools—fall short in studies that aim to unpack the psychedelic mechanism of action, so some behavioral neuroscientists are developing more nuanced tasks.
Psychedelics research in rodents has a behavior problem
Simple behavioral assays—originally validated as drug-screening tools—fall short in studies that aim to unpack the psychedelic mechanism of action, so some behavioral neuroscientists are developing more nuanced tasks.
By
Calli McMurray
19 December 2025 | 8 min read
New organoid atlas unveils four neurodevelopmental signatures
The comprehensive resource details data on microcephaly, polymicrogyria, epilepsy and intellectual disability from 352 people.
New organoid atlas unveils four neurodevelopmental signatures
The comprehensive resource details data on microcephaly, polymicrogyria, epilepsy and intellectual disability from 352 people.
By
Diana Kwon
17 December 2025 | 4 min read
Can neuroscientists decode memories solely from a map of synaptic connections?
Five experts discuss the progress, possibilities and hurdles of decoding a “nontrivial” memory from an organism just by analyzing its brain connectivity patterns.
Can neuroscientists decode memories solely from a map of synaptic connections?
Five experts discuss the progress, possibilities and hurdles of decoding a “nontrivial” memory from an organism just by analyzing its brain connectivity patterns.
By
Paul Middlebrooks
17 December 2025 | 1 min read